Abstract
The objective of this study is to explore the effect of implementing accompanying family management in gastroenterology patients during the COVID-19 epidemic. According to the guidelines for the prevention and control of COVID-19 issued by the National Health Commission and the Guangdong Provincial Health Commission, as well as the First Affiliated Hospital of Jinan University and patients’ demands, we implemented an accompanying family management system for gastroenterology patients. The management plan not only listed the permission criteria for accompanying family, but also offered escorts with COVID-19 nucleic acid testing, COVID-19 case screening, temperature measurement, symptom observation, health education, and health protection. The results of this study revealed the following main findings: From January 23 to April 23, 2020, a total of 438 inpatients and 113 family escorts were admitted to the hospital, who demonstrated 100% compliance with epidemic prevention and control measures, no infections, and an average score of 96.2 in the patient satisfaction survey. It can be concluded that the establishment and strict implementation of an accompanying family management system together with good epidemic prevention and control practices not only substantially reduces the accompanying family rate without compromising the quality and safety of patient care, but also effectively prevents in-hospital infections.
Highlights
IntroductionOn January 20, 2020, the National Health Commission of the People’s Republic of China issued Announcement No 1, which proposed that as an acute respiratory infectious disease, COVID-19 was defined as a category B infectious disease under the Law of the People’s Republic of China on the Prevention and Control of Infectious Diseases, and should be managed as a category A infectious disease [2]
Cases of COVID-19 were first reported in December 2019 in China [1]
On January 20, 2020, the National Health Commission of the People’s Republic of China issued Announcement No 1, which proposed that as an acute respiratory infectious disease, COVID-19 was defined as a category B infectious disease under the Law of the People’s Republic of China on the Prevention and Control of Infectious Diseases, and should be managed as a category A infectious disease [2]
Summary
On January 20, 2020, the National Health Commission of the People’s Republic of China issued Announcement No 1, which proposed that as an acute respiratory infectious disease, COVID-19 was defined as a category B infectious disease under the Law of the People’s Republic of China on the Prevention and Control of Infectious Diseases, and should be managed as a category A infectious disease [2]. The Department of Gastroenterology of the First Affiliated Hospital of Jinan University treated 438 non-COVID-19 patients with digestive system diseases during the epidemic spanning the Spring Festival. Of these patients, 61.44% were in a severe or critical condition, 5.51% were critically ill, and 55.93% were severely ill. The technical guidelines on the prevention and Guiyan Wen et al.: Implementation of Accompanying Family Management for Gastroenterology
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
